• Nyheter
  • Sykdommer
  • Kongresser
  • Samfunnet

Nyheter fra ESMO

  • Early Signs of Efficacy of New Targeted Agents and Immunotherapies Reportedfor Multiple Cancers at ESMO Congress 2021 [ESMO Congress 2021 Press Release] Early Signs of Efficacy of New Targeted Agents and Immunotherapies Reportedfor Multiple Cancers at ESMO Congress 2021 [ESMO Congress 2021 Press Release] Data from early clinical trials presented at the ESMO Congress 2021 suggest that new anticancer treatments are on the horizon, with a clear emphasis on precision medicine.

    Created on: Sep 24, 2021 | 09:21 am
    Sep 24, 2021 | 09:21 am
  • Vax-On Points to Maintenance of Active Anticancer Treatment Throughout the Whole COVID-19 Vaccination Schedule Vax-On Points to Maintenance of Active Anticancer Treatment Throughout the Whole COVID-19 Vaccination Schedule Findings from the Vax-On study show a favourable safety profile of mRNA-based COVID-19 vaccine in patients with solid tumours during active anticancer treatment

    Created on: Sep 24, 2021 | 08:40 am
    Sep 24, 2021 | 08:40 am
  • FDA Grants Accelerated Approval to Tisotumab Vedotin-tftv for Recurrent or Metastatic Cervical Cancer FDA Grants Accelerated Approval to Tisotumab Vedotin-tftv for Recurrent or Metastatic Cervical Cancer Evidence for efficacy is based on the results from the innovaTV 204 study

    Created on: Sep 23, 2021 | 08:45 am
    Sep 23, 2021 | 08:45 am
  • Addition of an EGFR Antibody to Fluorouracil/Folinic Acid Maintenance Therapy in RAS Wild-Type mCRC Addition of an EGFR Antibody to Fluorouracil/Folinic Acid Maintenance Therapy in RAS Wild-Type mCRC Findings from the PANAMA study (AIO KRK 0212)

    Created on: Sep 22, 2021 | 20:55 pm
    Sep 22, 2021 | 20:55 pm
  • A Novel Combination of Cabozantinib Plus Atezolizumab Demonstrates Encouraging Activity and Acceptable Tolerability in Advanced RCC A Novel Combination of Cabozantinib Plus Atezolizumab Demonstrates Encouraging Activity and Acceptable Tolerability in Advanced RCC Findings from the COSMIC-021 study

    Created on: Sep 21, 2021 | 16:44 pm
    Sep 21, 2021 | 16:44 pm

Powered by Warp Theme Framework
  • Nyheter
  • Sykdommer
  • Kongresser
  • Samfunnet